BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36417079)

  • 1. Progress in the relationship between P2X7R and colorectal cancer.
    Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
    Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of P2X7 receptor in prognosis and metastasis of colorectal cancer.
    Zhang Y; Ding J; Wang L
    Adv Med Sci; 2019 Sep; 64(2):388-394. PubMed ID: 31276917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.
    Wang X; Yu Q; Bai X; Li X; Sun Y; Peng X; Zhao R
    Eur J Cancer Prev; 2024 May; 33(3):271-281. PubMed ID: 37942897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
    Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
    Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
    Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
    Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome.
    Bernardazzi C; Castelo-Branco MTL; Pêgo B; Ribeiro BE; Rosas SLB; Santana PT; Machado JC; Leal C; Thompson F; Coutinho-Silva R; de Souza HSP
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563010
    [No Abstract]   [Full Text] [Related]  

  • 8. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic P2X7R as a potential target for pancreatic cancer.
    Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X
    Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ATP-P2X
    Wang-Fang J; Chun-Jie J; Fei G; Jia-Hui L; Ming L
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jul; 29(4):526-529. PubMed ID: 29508600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer.
    Zuo C; Xu YS; He PF; Zhang WJ
    Eur J Med Chem; 2023 Dec; 261():115877. PubMed ID: 37857146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic P2X7 receptor as a potential therapeutic target in depression.
    Qi W; Jin X; Guan W
    Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-gated P2X7 receptor as a potential target for prostate cancer.
    Qiao C; Tang Y; Li Q; Zhu X; Peng X; Zhao R
    Hum Cell; 2022 Sep; 35(5):1346-1354. PubMed ID: 35657562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.
    Martínez-Cuesta MÁ; Blanch-Ruiz MA; Ortega-Luna R; Sánchez-López A; Álvarez Á
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
    Safya H; Mellouk A; Legrand J; Le Gall SM; Benbijja M; Kanellopoulos-Langevin C; Kanellopoulos JM; Bobé P
    Front Immunol; 2018; 9():360. PubMed ID: 29535730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress of P2X7 receptor in inflammatory bowel disease.
    Liu Y; Liu X
    Scand J Gastroenterol; 2019 May; 54(5):521-527. PubMed ID: 31056977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of purinergic P2X
    McLarnon JG
    Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice.
    Le Gall SM; Legrand J; Benbijja M; Safya H; Benihoud K; Kanellopoulos JM; Bobé P
    PLoS One; 2012; 7(12):e52161. PubMed ID: 23284917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X7R promotes angiogenesis and tumour-associated macrophage recruitment by regulating the NF-κB signalling pathway in colorectal cancer cells.
    Yang C; Shi S; Su Y; Tong JS; Li L
    J Cell Mol Med; 2020 Sep; 24(18):10830-10841. PubMed ID: 32735377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.